Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,290.00
+30.00 (0.57%)
At close: Dec 5, 2025
1.15%
Market Cap 80.25B
Revenue (ttm) 110.29B
Net Income (ttm) 6.50B
Shares Out 15.17M
EPS (ttm) 428.21
PE Ratio 12.35
Forward PE n/a
Dividend 60.00 (1.13%)
Ex-Dividend Date Dec 29, 2025
Volume 20,096
Average Volume 27,916
Open 5,280.00
Previous Close 5,260.00
Day's Range 5,190.00 - 5,290.00
52-Week Range 4,700.00 - 8,730.00
Beta 0.07
RSI 52.14
Earnings Date Nov 13, 2025

About Sinsin Pharmaceutical

Sinsin Pharmaceutical Co., Ltd manufactures and sells pharmaceutical products in South Korea. It offers various medicinal products, such as plaster, aerosol, topical liquid, emollient, hygiene, and ointment products, as well as adhesive bandages, mosquito repellents, anti-perspirants, cooling sheets, bruise treatment creams, and other products. The company also develops transdermal drug delivery system, and bag on valve inhaler and aerosol solubilzation system. In addition, it exports its products to approximately 30 countries worldwide. The co... [Read more]

Industry Pharmaceutical Preparations
Founded 1959
Employees 356
Stock Exchange KOSDAQ
Ticker Symbol 002800
Full Company Profile

Financial Performance

In 2024, Sinsin Pharmaceutical's revenue was 106.39 billion, an increase of 3.71% compared to the previous year's 102.59 billion. Earnings were 4.89 billion, an increase of 4.46%.

Financial Statements

News

There is no news available yet.